Vous n'êtes pas connecté
ORCL's fiscal first-quarter results are likely to reflect rapid adoption and progress in AI-based cloud services offering potential for future...
Ebglyss provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled with topicals Patients...
Ebglyss provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled with topicals Patients...
FEMY gains after FDA clearance for FemChec, a fallopian tube diagnostic tool designed for safe, in-office use, enhancing non-surgical birth control...